Tirbanibulin
Category: Pharmaceutical
Exhibitor: PHARMAESSENTIA CORP.
Booth No: L118
Characteristic
PharmaEssentia Tirbanibulin was approved for the treatment of Actinic Keratosis by TFDA in September, 2022.
Other Products
Products you may be interested in
Highest Rated Products